Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

Bisphosphonates are the leading drugs for the treatment of osteoporosis. In randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ibandronate show antifracture efficacy at vertebra...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Pazianas, Michael, Cooper, Cyrus, Ebetino, F Hal, Russell, R Graham G
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2010
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2909499/
https://ncbi.nlm.nih.gov/pubmed/20668715
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki